Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The Lancet

Topics

Economics

Internal Medicine

Medicine

Pediatrics

Emergency Medicine

Show all topics

DOI

10.1016/s0140-6736(21)02249-2

License

other-oa